Acquiring an existing IV hydration clinic gives you immediate cash flow, a medical director in place, and a proven membership base — but building from scratch lets you design compliance and culture from day one. Here's how to decide.
IV therapy clinics occupy a unique corner of the healthcare and wellness market: they generate strong cash-pay revenue, operate without insurance billing complexity, and attract loyal clients willing to pay $150–$400 per infusion session. But they also carry real regulatory risk, heavy reliance on licensed clinical staff, and state-specific corporate practice of medicine rules that can make or break an ownership structure. For buyers and entrepreneurs evaluating entry into this $8–$11 billion market, the central question is whether to acquire an established clinic with existing infrastructure and patient flow, or to build a new location with full control over protocols, branding, and compliance from the start. Neither path is universally superior. Your decision should hinge on your capital position, risk tolerance, timeline to revenue, and whether you have — or can secure — a reliable medical director relationship. This analysis breaks down both paths with realistic costs, timelines, and trade-offs specific to the IV therapy clinic industry.
Find IV Therapy Clinic Businesses to AcquireAcquiring an existing IV therapy clinic means purchasing an operating business with a credentialed medical director agreement, trained nursing staff, an active membership base, and established supplier relationships with compounding pharmacies and IV supply vendors. In the lower middle market, quality IV therapy clinics with $500K+ EBITDA and documented recurring revenue trade at 3x–5.5x EBITDA. With SBA 7(a) financing covering 75–90% of the purchase price, qualified buyers can acquire a clinic generating $800K–$1.2M in annual revenue for a total cash outlay of $150K–$350K at closing, with the remainder financed over 10 years. The trade-off is inheriting legacy compliance issues, staff dependencies, and customer relationships that may or may not transfer cleanly.
Private equity-backed rollup platforms, physician groups adding a cash-pay service line, experienced healthcare entrepreneurs with SBA financing access, and operators who want proven revenue with a defined customer base rather than building brand awareness from zero.
Building a new IV therapy clinic from the ground up means selecting your own location, designing your compliance structure before the first infusion is administered, recruiting a medical director on your terms, and building a brand without inheriting someone else's regulatory history. Startup costs for a single clinic location range from $150K–$400K depending on market, build-out requirements, and whether you pursue a brick-and-mortar or hybrid mobile-plus-fixed model. The significant challenge is that you will generate zero revenue for 6–12 months while you secure licensing, hire staff, establish compounding pharmacy relationships, and build local brand awareness — and the first 18 months of operations are typically break-even or marginally profitable as membership ramps.
Nurses or nurse practitioners with an existing patient network and a physician willing to serve as medical director, entrepreneurs in underserved markets with no established IV therapy competition, and operators who prioritize compliance control and brand ownership over speed to revenue.
For most buyers with access to SBA financing and a target clinic generating $500K+ in revenue with a transferable medical director agreement, acquisition is the superior path. The ability to generate Day 1 cash flow, skip 12–18 months of brand building, and enter with an established membership base outweighs the premium paid at 3x–5.5x EBITDA — provided due diligence is thorough enough to surface legacy compliance risk and physician dependency. Building makes sense only when you have a specific market with no quality acquisition targets, a physician relationship already secured, and the capital and patience to survive an 18–24 month ramp. If you cannot answer 'yes' to all three, acquiring a clinic with clean financials and a retained medical director will generate a stronger risk-adjusted return in a shorter timeframe. The decisive factor in every case: the medical director. Whichever path you choose, your ability to secure, retain, and contractually protect a qualified physician supervisory relationship will determine whether your IV therapy clinic thrives or faces regulatory paralysis.
Do you have a physician willing to serve as medical director already identified and committed — or will you be recruiting one from scratch, adding 3–6 months and significant risk to either path?
Is there an acquisition target in your target market with at least 200 active members, 2+ years of operating history, and a medical director agreement that is documented and transferable to a new owner?
Can you qualify for SBA 7(a) financing that would allow you to acquire an established clinic with 10–15% down, making acquisition financially competitive with the full cash outlay required to build from scratch?
How much regulatory and operational risk are you willing to inherit — and do you have a healthcare compliance attorney who can conduct pre-LOI due diligence on state CPOM rules, prior licensing history, and compounding pharmacy relationships specific to the target clinic's jurisdiction?
What is your personal timeline and cash flow requirement — do you need revenue within 90 days of transaction close (strongly favoring acquisition), or can you sustain 12–24 months of pre-revenue operations while building a new clinic?
Browse IV Therapy Clinic Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Most IV therapy clinics generating $1M–$3M in annual revenue trade at 3x–5.5x EBITDA, putting total acquisition prices in the $900K–$3.5M range. With SBA 7(a) financing — which covers 75–90% of the purchase price for qualifying healthcare-adjacent businesses — buyers typically need $100K–$350K in equity at closing, plus $50K–$150K in working capital and transaction costs. Seller earnouts of 10–20% tied to 12-month post-close revenue retention are common deal structures that reduce upfront cash requirements.
A single brick-and-mortar IV therapy clinic typically costs $150K–$400K to open, covering lease deposits, build-out (IV infusion chairs, privacy dividers, medical-grade equipment), state licensing and health department fees, initial pharmaceutical and supply inventory, legal fees for compliance structure, and 6 months of operating capital. First-year marketing and membership acquisition adds $30K–$80K. Total all-in investment before reaching break-even membership revenue is typically $250K–$500K.
The corporate practice of medicine (CPOM) rules vary significantly by state and represent the most common source of post-close surprises. In strict CPOM states, a non-physician owner may be prohibited from directly employing physicians or controlling clinical decisions — meaning the acquisition structure must be carefully designed with healthcare legal counsel before closing. Equally critical is the medical director agreement: if the selling physician is not contractually committed to remain post-close, the clinic may lose its ability to operate legally within weeks of the transaction.
Most new IV therapy clinics reach operational break-even between 12–24 months after opening, assuming consistent membership growth. Membership programs generating $5,000–$15,000 per month in recurring revenue are typically the profitability inflection point — and building to 150–300 active members usually takes 12–18 months of active client acquisition. Acquired clinics with existing membership bases can be cash flow positive from Day 1, which is one of the strongest financial arguments for acquisition over building.
Yes — IV therapy clinics are generally SBA 7(a) eligible as operating businesses with documented cash flow, provided the buyer meets standard SBA borrower requirements (good credit, relevant experience, sufficient equity injection). The most common challenge is lender familiarity with cash-pay medical businesses. Working with an SBA lender experienced in healthcare-adjacent or med spa transactions significantly increases approval speed and reduces the risk of loan conditions that conflict with the deal structure. Seller notes of 10–20% are frequently used to bridge SBA loan proceeds to the full purchase price.
The highest-value IV therapy clinics have three things in common: a transferable medical director agreement with a physician willing to remain post-close, a documented monthly membership program with 200+ active members and measurable retention metrics, and at least 3 years of clean accrual-based financials reviewed or audited by a CPA. Diversified service menus including NAD+ therapy, peptide injections, and weight loss programs that increase average revenue per visit further support premium valuations at 4.5x–5.5x EBITDA. Clinics without these characteristics typically sell at 3x–4x or face significant buyer-side price adjustments.
More IV Therapy Clinic Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers